Pacer Advisors, Inc. Allakos Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$85.37 - $114.1 $54,039 - $72,225	-633 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$109.73 - $153.66 $28,529 - $39,951	-260 Reduced 29.12%	633 $73,000
Q4 2020 Jan 20, 2021	SELL	$79.58 - $152.45 $40,267 - $77,139	-506 Reduced 36.17%	893 $125,000
Q3 2020 Oct 19, 2020	BUY	$66.43 - $90.99 $92,935 - $127,295	1,399 New	1,399 $114,000

68.8M

20.9K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.